168 related articles for article (PubMed ID: 29449673)
1. The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients.
Rampazzo E; Del Bianco P; Bertorelle R; Boso C; Perin A; Spiro G; Bergamo F; Belluco C; Buonadonna A; Palazzari E; Lonardi S; De Paoli A; Pucciarelli S; De Rossi A
Br J Cancer; 2018 Mar; 118(6):878-886. PubMed ID: 29449673
[TBL] [Abstract][Full Text] [Related]
2. Predicting response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with serum biomarkers.
Clarke TL; White DA; Osborne ME; Shaw AM; Smart NJ; Daniels IR
Ann R Coll Surg Engl; 2017 May; 99(5):373-377. PubMed ID: 28462648
[TBL] [Abstract][Full Text] [Related]
3. Reappraisal of pretreatment carcinoembryonic antigen in patients with rectal cancer receiving preoperative chemoradiotherapy.
Yeo SG; Kim DY; Chang HJ; Park JW; Oh JH; Kim BC; Baek JY; Kim SY; Kim TH
Tumori; 2013; 99(1):93-9. PubMed ID: 23549007
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer.
Cheong C; Shin JS; Suh KW
World J Gastroenterol; 2020 Nov; 26(44):7022-7035. PubMed ID: 33311947
[TBL] [Abstract][Full Text] [Related]
5. Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation.
Lin CY; Tian YF; Wu LC; Chen LT; Lin LC; Hsing CH; Lee SW; Sheu MJ; Lee HH; Wang YH; Shiue YL; Wu WR; Huang HY; Hsu HP; Li CF; Chen SH
J Clin Pathol; 2012 Aug; 65(8):687-92. PubMed ID: 22569540
[TBL] [Abstract][Full Text] [Related]
6. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
[TBL] [Abstract][Full Text] [Related]
7. Histological grading based on poorly differentiated clusters is predictive of tumour response and clinical outcome in rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Reggiani Bonetti L; Lionti S; Domati F; Pagliani G; Mattioli E; Barresi V
Histopathology; 2017 Sep; 71(3):393-405. PubMed ID: 28425130
[TBL] [Abstract][Full Text] [Related]
8. Telomere-specific reverse transcriptase (hTERT) and cell-free RNA in plasma as predictors of pathologic tumor response in rectal cancer patients receiving neoadjuvant chemoradiotherapy.
Pucciarelli S; Rampazzo E; Briarava M; Maretto I; Agostini M; Digito M; Keppel S; Friso ML; Lonardi S; De Paoli A; Mescoli C; Nitti D; De Rossi A
Ann Surg Oncol; 2012 Sep; 19(9):3089-96. PubMed ID: 22395986
[TBL] [Abstract][Full Text] [Related]
9. Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
Lee JH; Song C; Kang SB; Lee HS; Lee KW; Kim JS
Anticancer Res; 2018 Dec; 38(12):6905-6910. PubMed ID: 30504408
[TBL] [Abstract][Full Text] [Related]
10. Blood biomarkers are helpful in the prediction of response to chemoradiation in rectal cancer: a prospective, hypothesis driven study on patients with locally advanced rectal cancer.
Buijsen J; van Stiphout RG; Menheere PP; Lammering G; Lambin P
Radiother Oncol; 2014 May; 111(2):237-42. PubMed ID: 24746569
[TBL] [Abstract][Full Text] [Related]
11. Pathological correlation with diffusion restriction on diffusion-weighted imaging in patients with pathological complete response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results.
Jang KM; Kim SH; Choi D; Lee SJ; Park MJ; Min K
Br J Radiol; 2012 Sep; 85(1017):e566-72. PubMed ID: 22422387
[TBL] [Abstract][Full Text] [Related]
12. Circulating serum microRNA-345 correlates with unfavorable pathological response to preoperative chemoradiotherapy in locally advanced rectal cancer.
Yu J; Li N; Wang X; Ren H; Wang W; Wang S; Song Y; Liu Y; Li Y; Zhou X; Luo A; Liu Z; Jin J
Oncotarget; 2016 Sep; 7(39):64233-64243. PubMed ID: 27572313
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of tumor budding in patients who had surgery for rectal cancer with and without neoadjuvant therapy.
Şirin AH; Sökmen S; Ünlü SM; Ellidokuz H; Sarioğlu S
Tech Coloproctol; 2019 Apr; 23(4):333-342. PubMed ID: 30900039
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Effect of Pretreatment Serum Carcinoembryonic Antigen Level: A Useful Tool for Prediction of Distant Metastasis in Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
Kim CH; Lee SY; Kim HR; Kim YJ
Medicine (Baltimore); 2015 Aug; 94(31):e1291. PubMed ID: 26252304
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted MRI for Early Prediction of Treatment Response on Preoperative Chemoradiotherapy for Patients With Locally Advanced Rectal Cancer: A Feasibility Study.
Jacobs L; Intven M; van Lelyveld N; Philippens M; Burbach M; Seldenrijk K; Los M; Reerink O
Ann Surg; 2016 Mar; 263(3):522-8. PubMed ID: 26106836
[TBL] [Abstract][Full Text] [Related]
16. YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study.
Senetta R; Duregon E; Sonetto C; Spadi R; Mistrangelo M; Racca P; Chiusa L; Munoz FH; Ricardi U; Arezzo A; Cassenti A; Castellano I; Papotti M; Morino M; Risio M; Cassoni P
PLoS One; 2015; 10(4):e0123759. PubMed ID: 25875173
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery.
Yang KL; Yang SH; Liang WY; Kuo YJ; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC; Chu LS; Wang LW
Radiat Oncol; 2013 Mar; 8():43. PubMed ID: 23452434
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of (18)FDG PET-CT for tumour response in patients with locally advanced rectal cancer treated by preoperative chemoradiotherapy.
Kim JW; Kim HC; Park JW; Park SC; Sohn DK; Choi HS; Kim DY; Chang HJ; Baek JY; Kim SY; Kim SK; Oh JH
Int J Colorectal Dis; 2013 Sep; 28(9):1217-24. PubMed ID: 23404344
[TBL] [Abstract][Full Text] [Related]
19. Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemo-radiotherapy before surgery in patients with locally advanced rectal cancer.
Schou JV; Larsen FO; Sørensen BS; Abrantes R; Boysen AK; Johansen JS; Jensen BV; Nielsen DL; Spindler KL
Ann Oncol; 2018 Mar; 29(3):610-615. PubMed ID: 29253083
[TBL] [Abstract][Full Text] [Related]
20. Comparative Outcomes of Preoperative Chemoradiotherapy and Selective Postoperative Chemoradiotherapy in Clinical Stage T3N0 Low and Mid Rectal Cancer.
Lin Y; Lin H; Xu Z; Zhou S; Chi P
J Invest Surg; 2019 Nov; 32(7):679-687. PubMed ID: 30215538
[No Abstract] [Full Text] [Related]
[Next] [New Search]
